About MolecularMatch
MolecularMatch is a Healthcare company based in Houston (United States) founded in 2013. SaaS platform for personalized medicine and clinical trials is offered. MolecularMatch has raised $3.69 million across 2 funding rounds from investors including Squarespace and Houston Angel Network. The company has 6 employees. MolecularMatch offers products and services including MMPower, MMLab, MMPortal, and MMTherapeutics. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Pharmacogenomics. Its legal entity is MolecularMatch Inc. Its competitors include Evidation, Helix and Benchling; 3 of its 3 listed competitors have raised funding.
Company details
MolecularMatch was founded in 2013 in Houston, United States, within the health technology sector. A SaaS-based platform is provided to match patients with personalized medicines using genetic disease signatures. Enrollment in global clinical trials is facilitated through a free database. Pharmacogenomics software tailored for pathology labs is also supplied to support targeted drug development and trial access.
- Headquarters Houston, United States
- Employees 6
- SectorsHealthcare
- Website molecularmatch.com
- Social LinkedIn X Facebook
- Legal Name Molecularmatch Inc.
- Total Equity Funding$3.69M (USD)
in 2 rounds
- Latest Funding Round$593K (USD), Series A
Aug 2014
- InvestorsSquarespace
& 1 more
- Employee Count6
Products & Services of MolecularMatch
MolecularMatch offers a comprehensive portfolio of products and services, including MMPower, MMLab, MMPortal, and MMTherapeutics.
Platform for clinical decision support in oncology.
Tool for processing and analyzing genomic data.
Portal for molecular knowledgebase and insights.
Solution for targeted molecular treatment options.
Funding Insights of MolecularMatch
MolecularMatch has successfully raised a total of $3.69M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $593 thousand completed in August 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.69M
- Total Rounds 2
- Last Round Series A — $593,000
- First Round $3.1M
(Jun 2014)
- Investors Count 2
All 2 funding rounds of MolecularMatch with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2014 | $593,000 | Series A | – | Squarespace | – |
| Jun 2014 | $3.1M | Series A | – | Houston Angel Network | – |
2 investors in total: 2 institutional.
Investors in MolecularMatch
MolecularMatch has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Squarespace and Houston Angel Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Houston Angel Network is focused on supporting startups with funding. | houstonangelnetwork.org | Houston, United States | ||
| ut-otc.squarespace.com/horizon-fund/ |
Investor details for MolecularMatch
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MolecularMatch
3 dated milestones of MolecularMatch across 1 years, from founding to its latest funding, stage changes and deals.
- Founded MolecularMatch is founded.
- Funding First funding round of $3.1M.
- Funding Latest funding round, Series A, of $593K.
Competitors of MolecularMatch
MolecularMatch has 3 listed competitors in our database, 3 of them funded. They include Evidation, Helix and Benchling.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evidation.com | 2012 | Menlo Park, United States | $259.16M | 196 | Real-world health data is provided for research and decisions. | |
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. |
Detailed competitors of MolecularMatch
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as MolecularMatch (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Molecularmatch
Complete news archive for MolecularMatch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MolecularMatch
MolecularMatch was founded in 2013 and raised its 1st funding round 1 year after it was founded.
MolecularMatch is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
MolecularMatch is a funded company, having raised a total of $3.69M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.1M, raised on Jun 2014.
MolecularMatch has 6 employees.
MolecularMatch was founded in 2013 in Houston, United States, within the health technology sector. A SaaS-based platform is provided to match patients with personalized medicines using genetic disease signatures. Enrollment in global clinical trials is facilitated through a free database. Pharmacogenomics software tailored for pathology labs is also supplied to support targeted drug development and trial access.
MolecularMatch offers MMPower, MMLab, MMPortal, and MMTherapeutics.
MolecularMatch has 2 investors. Key investors include Squarespace, and Houston Angel Network.
MolecularMatch operates through Molecularmatch Inc..